9999999997-14-007016.txt : 20140411 9999999997-14-007016.hdr.sgml : 20140411 20140411091932 ACCESSION NUMBER: 9999999997-14-007016 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20140411 DATE AS OF CHANGE: 20140411 20140411 20140411 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cerulean Pharma Inc. CENTRAL INDEX KEY: 0001401914 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1933 Act SEC FILE NUMBER: 333-194442 FILM NUMBER: 14758803 BUSINESS ADDRESS: STREET 1: 840 MEMORIAL DRIVE STREET 2: 5TH FLOOR CITY: Cambridge STATE: MA ZIP: 02139 BUSINESS PHONE: 617-551-9600 MAIL ADDRESS: STREET 1: 840 MEMORIAL DRIVE STREET 2: 5TH FLOOR CITY: Cambridge STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Tempo Pharmaceuticals Inc DATE OF NAME CHANGE: 20070604 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C0U(#`@;V)J#3P\+TQI;F5AF4@-3@O5'EP92]84F5F+U=;,2`R(#%=/CYS=')E86T-"FC>8F)D$&!@ M8F#R`A(,4X`$XPT@P1(&)-@S@<2G]PQ,C`Q[0+(,C.C$?\;I?P`"#`#5)@?D M#0IE;F1S=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@ M("`@#0HU-R`P(&]B:@T\/"]#(#8Y+T9I;'1E8F!@8&%@8(IF``*>G0RH@)$! M),O1@"S&`L4,##<8N!DX?WNT+(`JE>N'T$Q-R(J-"B&BC"8``08`3W0''PT* M96YD7!E+U!A9V4^/@UE;F1O8FH--#@@,"!O8FH-/#PO1FEL=&5R+T9L871E M1&5C;V1E+T9I+44PP$S&9,*.9,K`Q3&IEF(F9C(UD M#_QF.IUD3;YBH!7L[O'RDE\WR[QLF10JYM/LZ5->K#:SJFPGD^K7PX4Q">F8$D)0@$?2SK)=L7UYMRAV><-N\Y_LKMIEY7O2 MW6:[G),&%'3^=7XQJ;:K+PO2S]LZ;Y<;?EO5NVQ+1_<=(BL$OVFS;;&\+M?; MG`D^;_/=-R:CF"]>GG*R19Z*-O;J"/#%O-#EV^\=R6:V*'RX"#RJMTT M#]8F[%\*MD841=`>T!KP#WX2.%1@@$HR0*45W@&_J'=.;XF/8\4@<)Y& M@EFEH,DL?=TZEM*#C)*4;'&-NE3KSA;WS@[V!IH[C$.)A$&C("F32`^,0(*S MAL#N&YY[GWZ=]&NG]SX`-`IT!*HO`.E3&$8EZ&OP:_KBF`"'>X&PAG"A.V/OU0-$8&BA^TJJ$0`G"-9AL!IN*93TD>NJ!:* MH`=DW7GG;\T@)GBDL?@7I)8(A!()Q#L=Z'$$ZUID+-@^_B4/"-I@D<:"71"* M[X1#<72ZURE>!I]'HB5/O\"Q?TF_\3[]"GL>_;[)O/H(\R;B-/'JY"3QGLNY MYG_F7"T&^D1&09U,1J,OS*^35\)\-X@GSL_\A9^H+P2!R9EERDA(^)^F&=LS0(V``N>\&!RQ(HQSUM2 MD6;7`[+$-4.C7/?`@<(;-K8D6S':U;8:7OBY_J0/.K2]W\BFM'$-'V7L]6B! MIJV)VW94`*K\&"K28ZA0DJNL!8@J\K9H\$QZ1P68E45\_<-2W&!.$,0L%L$(*V$(X;!$.!E\$ M#<`6X&J.TQ%1+/'C+K`03N`Y`4$F0V\U`0=R=F\8`AC'2_3K0L-,\B2JKZYP MOZJ=/F4C&%RW#9XB MD3"DQ<5'+15.20Q1VEHT7-26_%WI(.+>I+V*)BR.`S^@5O M+[>P6]^*_QF>OC,U^"NB!%A=0,[V(7?M8(M&2[ MU3T$>">/Q:+I5/8M!Z?"5M!KFP"NP.0@"0I"=MI1E_9I#W5P;$?6+HD#:6U/ M[&'S"GT\,EA!+,TA=[G5F-(=I/1G.KYN0;LUJK@\I`K[N,6MLLD6A_*6Q-IH#'F+O!>4L.XI?G:$#<)H MIY):LS.$PIHDHNNGC8D7M7"Z=R-"$GBI\PE<5V,)2*5+2\HQRW1%&>T0X9/L MX28Y;5%*9N3J"S\Q8$'M$4-:1K:^I9R(-)7:T7BS';?+3$E>TE$T;>2>U&Y;VV#4 M#B2.G#%M.KB?!M)FZE04/&O8=AF>_DS6LFRW4RUH"Q00J8<]AM_Q!N-OQ^9T MLK2=U/K!;Q>VYFH=FF.C!!HD#+DRE1,=VT[L]V9==XC@\S;!XXD_XBIU`_`! M@Z$L&2;K-:7R<5VAZCI9UL42L[^M:[I$5=3I$OD&UEC]\'RYP&+(W,KIE+YJ ML;0G9KI)ANJQILJYT_L)GJ;/L\+!Q$O9B1Z&LPGE*R=SD4.F^.W%CC20O**C M-:EY-$%KDB4XFB&-[J0AS(U$19"*58EV$HR*EIX2P0#VO1/)UDCK3'54'FBB=I2T!4 M+#.?5/J]%".5J.L]I9,2WT:G_/^DD_PBG3*3B!3/8Y>M!Q=)F@C]$HOR=M*) M_PO=U!?K9CPDI7G11M%SU=!Q*?.:]"G1E7!QM,U5X5Y!@9$1FEP'Z>@8V!F0$,$I.+"QP#`GQ`[+S\O%0&#/#M M&@,CB+ZL"S(+4QXO8$TN*"H!T@>`V"@EM3@92'\!XLSRD@*@.&,"D"V2E`UF M@]2)9(<$.0/9'4`V7TEJ!4B,P3F_H+(H,SVC1,'0TM)2P3$E/RE5(;BRN"0U MMUC!,R\YOZ@@ORBQ)#4%J!9J!PCPNQ`P8A0[CQ!#@.32HC(HDY')F($!(,``2<8X+PT*96YDW)/1:MLP%(9? MY;R!K',DV882Z+H51ED6DNRJ],)+16K6VL9UH'W[_?;)NNUBI_>#D!_I''V2 M/]F)"BJI$JI(N*::)%3D"XHAD/=4IIH\4UDCT(,.'ZB*B$A5A4A4>T1)=4!4 M5)<(_(JB)BZ0@O1(@)B!+`IB08HGGK=(3!R1M1`G[(5)+I$Q$N,D7"6:=Q5L M(>#-Q\-2+]A'P`LXJX`7@L?1D263@!<+(0$O8E+`BRF2@!?K1#*?&YL$\%*L M"$M]PL,$\$H<^N+"W4!*05NW:<;<3?LQ9PCZ>V*=7Z:;_$K>;?O'_*49(&_N MV+\.V>VF\718VK9]/ZU6,_(6/M$P^UQ"-()&U$@:I4:EL8!GG4LHA97"2F&E ML%)8*:P45@HK190B2A&EB%)$*:(448HH190B2@E*"4H)"^7.;6A9XG9NEP_Z MU.O3T_/M_!XL'=V0].YJX=FG-QU>SR-V7ULF^/8/+T-QWZX M:H9?PT_=/=9FMY[_KF'V]^AS]]AV>??0P/ZY^^MIFN=T%]Q(^R/WI^D\/'U_ M/HSM\#8<\OCGQ!ZW^Z%_<95N7MWUY6YBWC7E;F;>=>5N: MMZVQ;8W?><=L:VQ;8]L:V];8ML:V-;:ML6U-;&OR3VL_!1@`)/C(\0T*96YD MFMC.60B/SX*/'@Z>&UP;65T M82!X;6QN#IX;7!T:STB061O8F4@6$U0 M($-O&UP.DUE=&%D871A1&%T93X*("`@("`@("`@/'AM<#I#&UP34TZ M&UP34TZ&UL.FQA;F<](G@M9&5F M875L="(O/@H@("`@("`@("`@("`\+W)D9CI!;'0^"B`@("`@("`@(#PO9&,Z M=&ET;&4^"B`@("`@("`@(#QD8SID97-C&UL.FQA;F<](G@M M9&5F875L="(O/@H@("`@("`@("`@("`\+W)D9CI!;'0^"B`@("`@("`@(#PO M9&,Z9&5S8W)I<'1I;VX^"B`@("`@("`@(#QD8SIC7=O#I3;W5R8V5-;V1I9FEE9#X*("`@("`@("`@/'!D M9G@Z0V]M<&%N>3Y396-U&AA;F=E($-O;6UI3X*("`@("`@("`@/'!D9G@Z0V]M;65N=',^5F5RC'<0%%5J>)@@4J5BF#.)6X;VL;(203W[_$A!B:V)^M[WY.[#BPL ME^VZEB.+J;EI[_ERH52R>27)D1/@W/Y<(5%7)%4^\*F?[NVF)G.T2[P%M<7-EN9NWLE]+)M1<>7(%M_[AQ)Q)`.T?8 ML\`;2VC:)QH_-633M!L._SNWPJ%Z4FG@@28E/,=!G(R35;_8<15/ZHG[2.&/ M"&]4A`K4X9U\T;&76,YDFM7J6X`!`"@]6*<-"F5N9'-T